newsfilter
← Latest News
GlobeNewswire·

Harvard Bioscience Announces First Quarter 2026 Financial Results

First Quarter 2026 Revenues of $20.8M and Gross Margin of 59%Consolidation of Manufacturing Operations Progressing on ScheduleReaffirms Full Year 2026 Financial Guidance HOLLISTON, Mass., May 12, 2026 (GLOBE